SUPPORT MEDICAL GROUP C.I.C.

Company Registration Number:
12129847 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2023

Period of accounts

Start date: 1 August 2022

End date: 31 July 2023

SUPPORT MEDICAL GROUP C.I.C.

Contents of the Financial Statements

for the Period Ended 31 July 2023

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

SUPPORT MEDICAL GROUP C.I.C.

Directors' report period ended 31 July 2023

The directors present their report with the financial statements of the company for the period ended 31 July 2023

Principal activities of the company

The principal activity of the company is that of providing medical support and ambulances to events and specific locations.



Directors

The director shown below has held office during the whole of the period from
1 August 2022 to 31 July 2023

Matthew Wilson


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 July 2024

And signed on behalf of the board by:
Name: Matthew Wilson
Status: Director

SUPPORT MEDICAL GROUP C.I.C.

Profit And Loss Account

for the Period Ended 31 July 2023

2023 2022


£

£
Turnover: 537,478 468,729
Cost of sales: ( 273,747 ) ( 278,736 )
Gross profit(or loss): 263,731 189,993
Distribution costs: ( 12,354 ) ( 5,479 )
Administrative expenses: ( 249,952 ) ( 103,697 )
Operating profit(or loss): 1,425 80,817
Profit(or loss) before tax: 1,425 80,817
Profit(or loss) for the financial year: 1,425 80,817

SUPPORT MEDICAL GROUP C.I.C.

Balance sheet

As at 31 July 2023

Notes 2023 2022


£

£
Fixed assets
Tangible assets: 3 13,157 16,985
Total fixed assets: 13,157 16,985
Current assets
Stocks: 4 48,527
Debtors: 5 6,057 874
Cash at bank and in hand: 5,390 65,095
Total current assets: 59,974 65,969
Creditors: amounts falling due within one year: 6 ( 3,915 ) ( 14,165 )
Net current assets (liabilities): 56,059 51,804
Total assets less current liabilities: 69,216 68,789
Total net assets (liabilities): 69,216 68,789
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 69,215 68,788
Total Shareholders' funds: 69,216 68,789

The notes form part of these financial statements

SUPPORT MEDICAL GROUP C.I.C.

Balance sheet statements

For the year ending 31 July 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 July 2024
and signed on behalf of the board by:

Name: Matthew Wilson
Status: Director

The notes form part of these financial statements

SUPPORT MEDICAL GROUP C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

    Tangible fixed assets depreciation policy

    Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives: 20% Straight Line Basis

SUPPORT MEDICAL GROUP C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 9 8

SUPPORT MEDICAL GROUP C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2023

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 August 2022 4,110 14,000 18,110
Additions
Disposals
Revaluations
Transfers
At 31 July 2023 4,110 14,000 18,110
Depreciation
At 1 August 2022 1,125 0 1,125
Charge for year 1,028 2,800 3,828
On disposals
Other adjustments
At 31 July 2023 2,153 2,800 4,953
Net book value
At 31 July 2023 1,957 11,200 13,157
At 31 July 2022 2,985 14,000 16,985

SUPPORT MEDICAL GROUP C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2023

4. Stocks

2023 2022
£ £
Stocks 48,527
Total 48,527

SUPPORT MEDICAL GROUP C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2023

5. Debtors

2023 2022
£ £
Trade debtors 5,457 874
Other debtors 600
Total 6,057 874

SUPPORT MEDICAL GROUP C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2023

6. Creditors: amounts falling due within one year note

2023 2022
£ £
Taxation and social security 998 12,128
Accruals and deferred income 1,800 1,800
Other creditors 1,117 237
Total 3,915 14,165

COMMUNITY INTEREST ANNUAL REPORT

SUPPORT MEDICAL GROUP C.I.C.

Company Number: 12129847 (England and Wales)

Year Ending: 31 July 2023

Company activities and impact

Company activities and impactWorking with our chosen Care Quality Commission (CQC) registered partners,, we are able to provide frontline emergency ambulances to transport patients. We have 4x4 off road ambulances that are able to get the patients where normal road ambulances may not be able to. Our 4x4 Ambulances have stretchers, so they arc able to transport the patient to the nearest road access point or field hospital for further treatment. We have First Responders and Emergency Care Attendants who are able to give life-saving medication and pain relief. All of our First Aid Team are able to monitor the patient and discharge with advice to further manage their healthcare needs, if required. We have the ability to set up medical centres for events. These can he one or two beds up to 10 beds within the field hospital equip with resuscitation areas. We also have the capability of performing minor surgical procedures such as, wound closure.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

The director Matthew Wilson was in receipt of £16,600 of directors remuneration.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
30 July 2024

And signed on behalf of the board by:
Name: M. Wilson
Status: Director